IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

June 18, 2010

Primary Completion Date

March 30, 2016

Study Completion Date

March 30, 2016

Conditions
Retinopathy of Prematurity (ROP)
Interventions
DRUG

rhIGF-I/rhIGFBP-3

Continuous intravenous infusion

Trial Locations (24)

26506

West Virginia University Hospital, Morgantown

27834

Vidant Medical Center, Greenville

30904

Georgia Regents Medical Center, Augusta

35128

University of Padua, Padua

53715

University of Wisconsin - Madison, Madison

73104

University of Oklahoma Health Sciences Center, Oklahoma City

92697

Univ of California Irvine Med Center, Irvine

36604-3391

University of South Alabama Children's and Women's Hospital, Mobile

39216-4505

Univ of Mississippi Medical Center, Jackson

Unknown

D.A.I. Materno Infantile, S.O.D. Neonatologia e Terapia Intensiva Neonatale - Azienda Ospedaliero-Universitaria Careggi, Florence

U.O.C Patologia e Terapia Intensiva Neonatale, Istituto Giannina Gaslini-Istituto Pediatrico di Ricovero e Cura a Carattere Scientifico, Genova

Dipartimento per la Tutella della Salute della Donna e della Vita Nascente, del Bambino e dell'Adolescente-U.O.C. Neonatologia-Poli. Gemelli, Rome

Skånes University Hospital Lund, Lund

Karolinska Universtitetssjukhuset i Huddinge, Stockholm

Alder Hey Children's NHS Foundation Trust, Liverpool

1081 HZ

VU medical Center, Amsterdam

93-338

Instytut Centrum Zdrowia Matki Polki, Lódz

60-535

Ginekologiczno-Położniczy Szpital Kliniczny Uniwersytetu Medycznego w Poznani, Poznan

CB2 0QQ

Addenbrookes Hospital, Cambridge

KT16 OPZ

St Peter's Hospital; Ashford & S, Chertsey

CV2 2DX

University Hospital, Coventry

WC1E 6AU

UCL EGA Institute for Women's Health, London

M13 9WL

St. Mary's Hospital, Manchester

NR4 7UY

Norfolk and Norwich University, Norwich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY